Cohance Life (COHANCE)
STALWARTFairStock Score: 50/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹363.85 |
| Market Cap | ₹11,857.67 Cr |
| P/E Ratio | 39.43 |
| ROCE | 14.89% |
| ROE | 16.51% |
| Dividend Yield | 0% |
| Profit Growth | -33.35% |
| Debt/Equity | 0.12 |
| Sales Growth | 23.2% |
| Free Cash Flow | ₹3,500 Cr |
| Promoter Holding | 57.49% |
| 52-Week Range | ₹266.7 — ₹1,121.15 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹44.35 |
Cohance Life trades with a P/E ratio of 39.43, ROCE of 14.89%, ROE of 16.51%, profit growth of -33.35%, debt-to-equity of 0.12. The FairStock Score of 50/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer